AntigenomYics, Inc. |
Antigenome technology for Ab Target Identification |
2019 |
|
Tellus Therapeutics, Inc. |
small molecules derived from human breast milk for treatment of brain injuries |
2019 |
Orphan Drug & Rare Pediatric Disease designations; $250K NCBC loan; $500K CTSI funding; $696 SBIR funding |
Basking Biosciences Inc. |
Antidote-controlled vWF inhibitor |
2019 |
$2.2M SBIR funding; $5.4M financing |
Lumedica Vision, Inc. |
ophthalmic imaging (OCT) |
2019 |
$1M NSF SBIR funding; $1M NIH SBIR funding; $900K 2020 revenues |
| |
|
|
|
Clinetic |
surgical big data project |
2017 |
$6.5M financing |
OmniSono, Inc. |
3D Ultrasound imaging |
2018 |
|
Gateway Bio |
polymer systems for diagnostics and drug delivery |
2017 |
|
Higgs Boson, LLC |
software app for supporting patients and their caregivers throughout their entire surgical journey, from planning to recovery and rehabilitation |
2017 |
$870K financing; $250K NCBC loan |
TRPblue |
Topical treatment for pain |
2017 |
|
Innovations 4 Surgery, LLC |
Ultrasonic bone saw |
2017 |
|
Eydis Bio, Inc. |
A platform of tethered molecules that enable both detection and ablation of malignant tumors |
2016 |
|
Mastezellen Bio, Inc. |
Therapeutics for treatment of diseases and disorders with mast cell involvement |
2016 |
|
 |
Products for vascular access & hemodialysis |
2015 |
$2M Financing; $2M Phase II NIH SBIR funding, $3M Phase IIB; NSF $800K SBIR funding; FDA-approved IDE |
Upstream Therapeutics, Inc. |
Therapeutics for treating inflammation and disorders involving immune activation |
2015 |
|
Deep Blue Medical Advances, Inc. |
Surgical mesh for hernia repair |
2015 |
STTR Grant ($225K); CTSA Pilot Award ($100K); NC Biotechnology Center (NCBC) (i) Technology Enhancement Grant ($75K); ii) Loan ($250K); $1.5M financing; FDA 510K Clearance |
 |
Biotherapies for treating autoimmunity and oncology |
2015 |
$2.5M Financing |
